Updated: January 7, 2026
How to Save Money on Skyrizi (Risankizumab) in 2026: Coupons, Discounts, and Patient Assistance
Author
Peter Daggett

Summarize with AI
- Skyrizi Complete Savings Card (Commercially Insured Patients)
- AbbVie Bridge Program (PA Denied or Delayed)
- myAbbVie Assist (Uninsured or Underinsured Patients)
- PAN Foundation: For Medicare Patients (Up to $4,000/Year)
- What About GoodRx and Other Discount Coupons?
- How to Reduce Your Out-of-Pocket Cost: A Quick Decision Guide
- Once You Have Financial Assistance, Finding a Pharmacy Is the Next Step
Skyrizi costs ~$22,000 per dose without insurance. Here's every savings program, coupon, and patient assistance option available to reduce your out-of-pocket cost in 2026.
Skyrizi (risankizumab-rzaa) is one of the most effective biologics available for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It is also among the most expensive medications on the market, with a list (WAC) price of approximately $22,383 per dose as of early 2025. For patients receiving quarterly injections for psoriasis or PsA, that adds up to more than $90,000 per year at list price — before insurance or assistance programs.
The good news: very few patients actually pay the list price. AbbVie offers a range of savings programs, and most commercially insured patients can reduce their out-of-pocket cost dramatically — sometimes to $0. Here's everything available in 2026.
Skyrizi Complete Savings Card (Commercially Insured Patients)
The Skyrizi Complete Savings Card is AbbVie's primary cost-assistance program for patients with commercial (private) insurance. Eligible patients may pay as little as $0 per quarterly dose.
To qualify:
You must have commercial (private) insurance that covers Skyrizi
You must be 63 years old or younger
The savings card is NOT available to Medicare, Medicaid, TRICARE, or other government-funded insurance beneficiaries
To enroll, call 1-866-SKYRIZI (1-866-759-7494) or visit SKYRIZISavingsCard.com. Important: if your plan uses an "accumulator adjustment" or "co-pay maximizer" program, the savings card benefit may be limited — ask your pharmacist about your plan's specific rules.
AbbVie Bridge Program (PA Denied or Delayed)
If your prior authorization is denied and you are appealing, AbbVie's bridge program through Skyrizi Complete can provide Skyrizi at no charge for up to 2 years — or until insurance approval is obtained, whichever comes first.
Eligibility: commercially insured patients aged 63 or younger, valid Skyrizi prescription, PA denial on file with a confirmed appeal. Call 1-866-SKYRIZI to enroll and confirm eligibility. The program does not have any purchase requirements.
myAbbVie Assist (Uninsured or Underinsured Patients)
If you have no insurance or your insurance does not cover Skyrizi, myAbbVie Assist may provide the medication at no charge based on your income and household size. There are no hard income cutoffs publicly listed, but the program is designed for patients who genuinely cannot afford the medication.
To apply: Call 1-800-222-6885 or visit AbbVie.com/PatientAccessSupport. Have your income information, insurance status, and Skyrizi prescription ready.
PAN Foundation: For Medicare Patients (Up to $4,000/Year)
Medicare patients cannot use the Skyrizi Complete Savings Card. However, they may qualify for grant funding through the Patient Access Network (PAN) Foundation's Inflammatory Bowel Disease fund. This fund can provide up to $4,000 per year in out-of-pocket cost assistance for eligible Medicare beneficiaries with Crohn's disease or ulcerative colitis.
Grant availability depends on fund status and changes throughout the year. Contact the PAN Foundation at panfoundation.org or call 1-866-316-7263 to check eligibility and current fund availability.
What About GoodRx and Other Discount Coupons?
GoodRx and similar pharmacy discount programs generally cannot be used for specialty biologics like Skyrizi. Skyrizi is not stocked at retail pharmacies where GoodRx is accepted. GoodRx coupons are not compatible with specialty pharmacy dispensing systems for this medication.
The primary savings options for Skyrizi are through AbbVie's own programs and patient assistance foundations — not third-party coupon services.
How to Reduce Your Out-of-Pocket Cost: A Quick Decision Guide
Commercial insurance, ≤63 years old: Enroll in Skyrizi Complete Savings Card → potentially $0/dose
Commercial insurance, PA denied, ≤63 years old: Apply for AbbVie bridge program → free medication for up to 2 years while appealing
Uninsured or underinsured: Apply for myAbbVie Assist → free medication based on income
Medicare with IBD: Apply for PAN Foundation IBD fund → up to $4,000/year
Once You Have Financial Assistance, Finding a Pharmacy Is the Next Step
After you've secured coverage or financial assistance, you still need to find a specialty pharmacy that can fill your prescription. medfinder is a paid service that calls specialty pharmacies near you to find which ones can fill your Skyrizi prescription — so you don't have to spend hours on hold.
See also: How to Find Skyrizi In Stock Near You for a step-by-step pharmacy location guide.
Frequently Asked Questions
Skyrizi's list (WAC) price is approximately $22,383 per dose as of early 2025. For psoriasis and PsA patients receiving quarterly doses, the annual list price exceeds $90,000. Without insurance or patient assistance programs, this cost is prohibitive. AbbVie's myAbbVie Assist program may provide Skyrizi at no charge for uninsured or underinsured patients who qualify.
Call 1-866-SKYRIZI (1-866-759-7494) or visit SKYRIZISavingsCard.com to enroll. You must be commercially insured, 63 years old or younger, and have a valid prescription for an FDA-approved Skyrizi indication. The savings card is not available to Medicare, Medicaid, TRICARE, or other government-funded insurance beneficiaries.
No. GoodRx and similar coupon programs generally cannot be used for Skyrizi. The medication is only available through specialty pharmacies, which do not accept retail discount coupons. For cost assistance, use AbbVie's programs: Skyrizi Complete Savings Card (commercial insurance), myAbbVie Assist (uninsured), or PAN Foundation (Medicare patients with IBD).
Yes. Skyrizi is covered by Medicare Part B when administered by a healthcare provider in a clinical setting (IV infusion), or Medicare Part D for self-injected doses at home. Coverage levels vary by plan. Medicare patients cannot use the AbbVie Savings Card, but may qualify for PAN Foundation IBD fund grants of up to $4,000/year, subject to fund availability.
AbbVie's bridge program provides Skyrizi at no charge for up to 2 years for commercially insured patients who are ≤63 years old, have a PA denial on file, and have submitted a confirmed appeal. The program bridges treatment while the insurance appeal is pending. Call 1-866-SKYRIZI to enroll.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Risankizumab also looked for:
More about Risankizumab
32,900 have already found their meds with Medfinder.
Start your search today.





